Jersey R&O 93/2002

 

Medicines (Jersey) Law 1995

____________

 

MEDICINES (SALE AND SUPPLY) (MISCELLANEOUS PROVISIONS) (AMENDMENT No. 4) (JERSEY) ORDER 2002

____________

 

                THE HEALTH AND SOCIAL SERVICES COMMITTEE, in pursuance of Articles 52 and 111 of the Medicines (Jersey) Law 1995,[1] as amended, and after consultation with the Medicines Advisory Council and having otherwise complied with Article 111 of that Law, orders as follows -

 

                1.      For Article 4 of the Medicines (Sale and Supply) (Miscellaneous Provisions) (Jersey) Order 1997,[2] as amended,[3] there shall be substituted the following Article -

 

“Additional conditions for sale or supply elsewhere than at pharmacy

 

          4.-(1)  Where a medicinal product is in the course of a business sold by retail, offered or exposed for sale by retail, or supplied in circumstances corresponding to retail sale, elsewhere than at a pharmacy, the conditions in the following paragraphs of this Article are prescribed conditions for the purpose of Article 52 of the Law.

 

          (2)     Where the medicinal product is for human use and contains aloxiprin, aspirin or paracetamol, the product shall be presented for sale in a separate and individual container, or package, containing -

 

          (a)     in the case of effervescent tablets that do not include aspirin or in which the amount of aspirin does not exceed 325 milligrams per tablet, not more than 30 tablets;

 

          (b)     in the case of effervescent tablets that include aspirin, where the amount of aspirin exceeds 325 milligrams per tablet but does not exceed 500 milligrams per tablet, not more than 20 tablets;

 

          (c)     in the case of tablets that are not effervescent, where they are enteric-coated and contain aspirin only and the amount of aspirin in each tablet does not exceed 75 milligrams, not more than 28 tablets;

 

          (d)     in the case of tablets that are not effervescent, where they are not tablets to which sub-paragraph (c) applies, not more than 16 tablets;

 

          (e)     in the case of powder or granules, not more than 10 sachets;

 

          (f)      in the case of capsules, not more than 16 capsules;

 

          (g)     in the case of liquid preparations of paracetamol that are intended for persons aged not less than 12 years, not more than 160 millilitres of the product; and

 

          (h)     in the case of liquid preparations of paracetamol that are intended for persons aged less than 12 years, individual unit doses (to a maximum of 20 unit doses) not exceeding five millilitres each.

 

          (3)     Where the medicinal product is for human use and contains sodium picosulphate -

 

          (a)     in the case of gel-filled capsules, the product shall be presented in a separate and individual container, or package, containing not more than 24 capsules; and

 

          (b)     in any other case, the product shall be presented for sale in a separate and individual container, or package, containing not more than 60 millilitres of the product.

 

          (4)     Where the medicinal product is for human use and contains loperamide hydrochloride, the product shall be presented for sale in a separate and individual container, or package, containing not more than six tablets or capsules.

 

          (5)     Where the medicinal product is for human use and contains mepyramine maleate, the product shall be presented for sale in a separate and individual container or package containing not more than 20 grams of the product.

 

          (6)     Where the medicinal product is for human use and contains bisacodyl, the product shall be presented for sale in a separate and individual container or package containing not more than 20 tablets.

 

          (7)     Where the medicinal product is for human use and contains heparinoid, the product shall be presented for sale in a separate and individual container or package containing not more than 20 grams of the product.”.

 

                2.      The following Orders shall be revoked -

 

                (a)     Article 2 of the Medicines (Sale and Supply) (Miscellaneous Provisions) (Amendment) (Jersey) Order 1998;[4]

 

                (b)     the Medicines (Sale and Supply) (Miscellaneous Provisions) (Amendment No. 2) (Jersey) Order 2000;[5]

 

                (c)     the Medicines (Sale and Supply) (Miscellaneous Provisions) (Amendment No. 3) (Jersey) Order 2001.[6]

 

                3.      This Order may be cited as the Medicines (Sale and Supply) (Miscellaneous Provisions) (Amendment No. 4) (Jersey) Order 2002 and shall come into force on 1st October 2002.

 

                By Order of the Health and Social Services Committee,

 

                                                                                            C.M. NEWCOMBE

 

Greffier of the States.

 

16th September 2002.